| Ethgen O, Schneider AG, Bagshaw SM, Bellomo R, Kellum JA. Economics of dialysis dependence following renal replacement therapy for critically ill acute kidney injury patients. Nephrology Dialysis Transplantation 2014; In press. |
| Slomian J, Reginster JY, Ethgen O, Appelboom G, Bruyere O. Interest of eHealth and mHealth for patients and caregivers. Austin Journal of Public Health & Epidemiology 2014; In press. |
| Launois R, Navarrete LF, Ethgen O, Le Moine JG, Gatsinga R. Health economic value of an innovation: delimiting the scope and framework of future market entry agreements. Journal of Market Access & Health Policy 2014; 2: 24988 – http://dx.doi.org/10.3402/jmahp.v2.24988 |
| Slomian J, Appelboom G, Ethgen O, Reginster JY, Bruyere O. Can new information and communication technologies help in the management of osteoporosis? Women’s Health 2014;10:229-32. http://dx.doi.org/10.2217/whe.14.15 |
| Ethgen O. Risk-sharing: Supplementing clinical trials for payer and HTA success. Journal for Clinical Studies 2014;6:30-31. http://jforcs.com/jcs/risk-sharing-for-payer-hta-success/ |
| Launois R, Ethgen O. Risk-sharing agreements: choice of study design and assessment criteria [French]. Annales Pharmaceutiques Françaises 2013;71:346-57. http://dx.doi.org/10.1016/j.pharma.2013.08.009 |
| Ethgen O, de Lemos Esteves F, Bruyere O, Reginster JY. What do we know on the safety of corticosteroids in rheumatoid arthritis. Current Opinion in Medical Research 2013;9:1147-60. http://dx.doi.org/10.1185/03007995.2013.818531 |
| Bruyere O, Ethgen O, Neuprez A, Zegels B, Gillet P, Huskin JP, Reginster JY. Health-related quality of life after total knee or hip replacement for osteoarthritis: A 7-year prospective study. Archives of Orthopaedic and Trauma Surgery 2012;132:1583-7. http://dx.doi.org/10.1007/s00402-012-1583-7 |
| Ethgen O, Standaert B. Population versus cohort-based modelling approaches. Pharmacoeconomics 2012;30:171-81. http://dx.doi.org/10.2165/11593050-000000000-00000 |
| Hiligsmann M, Gathon HJ, Bruyere O, Ethgen O, Rabenda V, Reginster JY. Cost-effectiveness of osteoporosis screening followed by treatment: The impact of medication adherence. Value in Health 2010;13:394-401. http://dx.doi.org/dx.doi.org/10.1111/j.1524-4733.2009.00687.x |
| Hiligsmann M, Rabenda V, Gathon HJ, Ethgen O, Reginster JY. Potential clinical and economic impact of nonadherence with osteoporosis medications. Calcified Tissue International 2010;86:202-10. http://dx.doi.org/10.1007/s00223-009-9329-4 |
| Hiligsmann M, Ethgen O, Bruyère O, Richy F, Gathon HJ, Reginster JY. Development and validation of a Markov microsimulation model for the economic evaluation of treatments in osteoporosis. Value in Health 2009;12:687-96. http://dx.doi.org/10.1111/j.1524-4733.2008.00497.x |
| Hiligsmann M, Ethgen O, Bruyère O, Gathon HJ, Reginster JY. Lifetime absolute risk of hip and other osteoporotic fracture in Belgian women. Bone 2008;43:991-4. http://dx.doi.org/10.1016/j.bone.2008.08.119 |
| Hiligsmann M, Ethgen O, Bruyère O, Reginster JY. An economic evaluation of quantitative ultrasonometry as pre-screening test for the identification of patients with osteoporosis. Disease Management and Health Outcomes 2008;16:429-38. http://dx.doi.org/10.2165/0115677-200816060-00008 |
| Hiligsmann M, Ethgen O, Richy F, Reginster JY. Utility values associated with osteoporotic fracture: a systematic review of the literature. Calcified Tissue International 2008;82:288-92. http://dx.doi.org/10.1007/s00223-008-9117-6 |
| Neuprez A, Hiligsmann M, Bruyère O, Ethgen O, Reginster JY. Prevention of hip fractures in osteoporosis. Minerva Ortopedica e Traumatologica 2007;58:423-37. |
| Rabenda V, Burlet N, Ethgen O, Raeman F, Belaiche J, Reginster JY. A naturalistic study of the determinants of health-related quality of life improvement in osteoarthritic patients treated with non-specific non-steroidal anti-inflammatory drugs. Annals of the Rheumatic Diseases 2005;64:688-93. |
| Richy F, Schacht E, Bruyère O, Ethgen O, Gourlay M, Reginster JY. Vitamin D Analogs versus Native Vitamin D in preventing bone loss and osteoporosis-related fractures: A comparative meta-analysis. Calcified Tissue International 2005;76:176-86. |
| Bruyère O, Wuidart MA, Di Palma E, Gourlay M, Ethgen O, Richy F, Reginster JY. Controlled whole body vibration to decrease fall risk and improve health-related quality of life of nursing home residents. Archives of Physical Medicine and Rehabilitation 2005;86:303-7. |
| Ethgen O, Bruyère O, Richy F, Dardennes C, Reginster JY. Health-related quality of life in total hip and knee arthroplasties. A qualitative and systematic review of the literature. Journal of Bone and Joint Surgery 2004;86-A:963-74. |
| Richy F, Ethgen O, Bruyère O, Reginster JY. Efficacy of alphacalcidol and calcitriol in primary and corticosteroid-induced osteoporosis : A meta-analysis of their effects on bone mineral density and fracture rate. Osteoporosis International 2004;14:179-90. |
| Ethgen O, Reginster JY. Is the demographic transition impacting on the perception of degenerative musculoskeletal disorders? Annals of the Rheumatic Diseases 2004;63:1-3. |
| Richy F, Gourlay M, Ross PD, Sen SS, Radican L, De Ceulaer F, Ben Sedrine W, Ethgen O, Bruyère O, Reginster JY. Validation and comparative evaluation of the Osteoporosis Self-Assessment Tool (OST) in a Caucasian population from Belgium. Quaterly Journal of Medicine 2004; 97:39-46. |
| Ethgen O, Van Parijs P, Delhalle S, Rosant S, Bruyère O, Reginster JY. Social support and health-related quality of life in hip and knee osteoarthritis. Quality of Life Research 2004;13:321-30. |
| Ben Sedrine W, Ethgen O, Devogelaer JP, Depresseux G, Kaufman JM, Goemaere S, Reginster JY. Evaluation of the proposals of the Belgian Social Security Institute for the reimbursement of bone densitometry. Toward a cost-effective strategy for osteoporosis screening? Aging Clinical and Experimental Reseacrh 2004;16:413-9. |
| Richy F, Bruyère O, Ethgen O, Rabenda V, Bouvenot G, Audran M, Herrero-Beaumont G, Moore A, Eliakim R, Haim M, Reginster JY. Time-dependant risk of gastrointestinal complications induced by NSAIDs use: A consensus statement using meta-analytic approach. Annals of the Rheumatic Diseases 2004;63:759-66. |
| Ethgen O, Gillain D, Gillet P, Gosset C, Jousten A, Reginster JY. Age- and sex-stratified prevalence of physical disabilities and handicap in the general population. Aging Clinical and Experimental Research 2004;16:389-97. |
| Richy F, Deceulaer F, Ethgen O, Bruyère O, Reginster JY. Development and validation of the ORACLE score to predict risk of osteoporosis. Mayo Clinic Proceedings 2004;79:1402-8. |
| Richy F, Ethgen O, Bruyère O, Mawet A, Reginster JY. Primary prevention of osteoporosis: mass screening scenario or pre-screening with questionnaires? An economic perspective. Journal of Bone and Mineral Research 2004;19:1955-60. |
| Bruyère O, Honoré A, Ethgen O, Rovati LC, Giacovelli G, Henrotin Y, Seidel L, Reginster JY. Correlation between radiographic severity of knee osteoarthritis and future disease progression. Results from a 3-year prospective, placebo-controlled study evaluating the effect of glucosamine sulphate. Osteoarthritis and Cartilage 2003;11:1-5. |
| Ethgen O, Tellier V, Ben SedrineW, De Maeseneer J, Gosset C, Reginster JY. Health-related quality of life and cost of ambulatory care in osteoporosis: How may such outcome measures be valuable information to health decision makers and payers? Bone 2003;32:718-24. |
| Richy F, Bruyère O, Ethgen O, Cucherat M, Henrotin Y, Reginster JY. Structural and symptomatic efficacy of glucosamine and chondroitin sulfate in knee osteoarthritis: A comprehensive meta-analysis. Archives of Internal Medicine 2003;163:1514-22. |
| Bruyère O, Colette J, Ethgen O, Rovati LC, Giacovelli G, Henrotin YE, Seidel L, Reginster JY. Biochemical markers of bone and cartilage remodelling in prediction of long-term progression of knee osteoarthritis. Journal of Rheumatology 2003;30:1043-50. |
| Ethgen O, Richy F, Hanssens L, Gosset L, Reginster JY. Prevention of frailty in the elderly: A demographic challenge. [French]. Revue Médicale de Liège 2003;58:175-82. |
| Ethgen O, Tancredi A, Lejeune E, Kvasz A, Zegels B, Reginster JY. Do utility values and willingness to pay suitably reflect health outcome in hip and knee osteoarthritis? A comparative analysis with the WOMAC. Journal of Rheumatology 2003;30:2452-9. |
| Bruyère O, Dardennes C, Lejeune E, Zegels B, Pahaut A, Richy F, Seidel L, Ethgen O, Henrotin Y, Reginster JY. Subchondral tibial bone mineral density predicts future joint space narrowing at the medial femero-tibial compartment in patients with knee osteoarthritis. Bone 2003;32:541-5. |
| Ethgen O, Kahler KH, Kong SX, Reginster JY, Wolfe F. The effect of health-related quality of life on reported use of health care resources in patients with osteoarthritis and rheumatoid arthritis: A longitudinal analysis. Journal of Rheumatology 2002;29:1147-55. |
| Ethgen O, Reginster JY. Quality of life assessment in clinical trials: A holistic approach to health. [French]. Revue Médicale de Liège 2002;57:695-700. |
| Reginster JY, Ethgen O, Dang Vu T. The chondroprotection today. [French]. Rhumatologie 2000;52:13-6. |
| Reginster JY, Gillet P, Ben Sedrine W, Brands G, Ethgen O, De Froimont C, Gosset C. Direct costs of hip fractures in patients over 60 years old in Belgium. Pharmacoeconomics 1999;15:507-14. |